专题：Spondyloarthritis Studies and Treatments

This cluster of papers focuses on the classification, diagnosis, and treatment of spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis. It covers the development of new classification criteria, assessment of disease activity, use of biologic therapies such as tumor necrosis factor inhibitors and interleukin-17 inhibitors, and the impact of genetic factors like HLA-B27.
最新文献
Psoriatic Disease as a Systems Transition — A Universal Resonance Model (URM) Perspective

preprint Full Text OpenAlex

Magnetic Resonance Spectroscopy Lipids Peak May Serve as a Potential Biomarker for Back Pain in Intervertebral Disc Degeneration: An Integrative Metabolomics and Proteomics Study Investigating the Role of the Lipid Droplets-Interleukin-17 Inflammatory Axis

article Full Text OpenAlex

Changes in weight associated with tumor necrosis factor inhibition in psoriatic arthritis: results from a retrospective cohort study

article Full Text OpenAlex

Digital Behavioral Therapy Improves Outcome in Patients With Axial Spondyloarthritis and Persistent Pain: A Randomized Controlled Trial

article Full Text OpenAlex

Matrix Metalloproteinase-9 as a Biomarker for Diagnosis and Monitor Disease Progression in Psoriatic Arthritis

article Full Text OpenAlex

Asperosaponin VI alleviates intervertebral disc degeneration by suppressing nucleus pulposus cell pyroptosis through modulation of the NF-κB/NLRP3 signaling pathway

article Full Text OpenAlex

Predicting Treatment Outcomes in Patients With Psoriatic Arthritis or Axial Spondyloarthritis: An Artificial Intelligence–Driven Approach

article Full Text OpenAlex

Detailed assessment of axial and peripheral entheses and joints in axial spondyloarthritis and psoriatic arthritis patients treated with ixekizumab (DAPHNE): design of a 2-year phase IV trial applying whole-body MRI, MRI-based synthetic CT, and CT

article Full Text OpenAlex

Serum Levels of 54 Cytokines and Chemokines Reveal Distinct Inflammatory Signatures in Ankylosing Spondylitis

article Full Text OpenAlex

The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritis

review Full Text OpenAlex

近5年高被引文献
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

article Full Text OpenAlex 776 FWCI192.53675732

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

review Full Text OpenAlex 530 FWCI131.88138672

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

article Full Text OpenAlex 322 FWCI80.53825143

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

review Full Text OpenAlex 249 FWCI258.16672659

Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults

article Full Text OpenAlex 234 FWCI27.27957213

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

review Full Text OpenAlex 205 FWCI51.59481732

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis

article Full Text OpenAlex 187 FWCI46.81285864

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

article Full Text OpenAlex 177 FWCI68.6650131

Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

article Full Text OpenAlex 147 FWCI36.49389518

Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice

article Full Text OpenAlex 143 FWCI35.48716704